By ,
Published October 24, 2015
Biotechnology company Novavax Inc said data from a mid-stage study showed that immunizing a pregnant woman with its RSV vaccine was safe for her fetus.
The trial tested the vaccine against a placebo in 50 healthy pregnant women in their third trimester.
Women who received placebo showed no significant change in their antibody levels, the company said.
https://www.foxnews.com/health/novavax-rsv-vaccine-given-to-mothers-safe-for-fetus-study-finds